SARAH JASPERS: Open Payments
NPI 1467780437 · GOODYEAR, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,586 in 85 payments from 21 companies in 2025. Trend: 2023 $1,667 · 2024 $2,049 · 2025 $1,586
Food & beverage: $1,586
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 17 | $291 |
| Astellas Pharma US Inc | 8 | $205 |
| AstraZeneca Pharmaceuticals LP | 7 | $145 |
| Lilly USA, LLC | 13 | $137 |
| Merck Sharp & Dohme LLC | 5 | $98 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $82 |
| GlaxoSmithKline, LLC. | 4 | $82 |
| Novartis Pharmaceuticals Corporation | 3 | $79 |
| Dexcom, Inc. | 4 | $78 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $75 |
Products named: Veozah, ELIQUIS, AIRSUPRA, Kerendia, TRELEGY ELLIPTA, MOUNJARO, LEQVIO, Dexcom G6 Transmitter.
Industry payments across AZ — which companies pay providers there.
